Clinical trial
Clinical Outcomes and Prognostic Factors of Robotic Assisted Rectal Cancer Resection Alone vs. Robotic Rectal Cancer Resection With Natural Orifice Specimen Extraction
NCT04265417 is registered in ClinicalTrials.gov with Taiyuan Li as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Outcomes and Prognostic Factors of Robotic Assisted Rectal Cancer Resection Alone vs. Robotic Rectal Cancer Resection With Natural Orifice Specimen Extraction
- Lead sponsor
- Taiyuan Li
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 6, 2015
- Completion date
- December 1, 2016
- Enrollment
- 98 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
natural orifice specimen extraction surgery, rectal neoplasms, robotic surgery